ArticleParasites & vectors2025
Efficacy of Vector Guard®, a mosaic alpha-cypermethrin and piperonyl butoxide-treated net, for the control of pyrethroid-resistant malaria vectors: a non-inferiority experimental hut evaluation in Benin.
Article in Parasites & vectors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Experimental hut evaluation of mosquito shield, a transfluthrin spatial emanator, for control of wild pyrethroid resistant malaria vectors in Benin.Scientific reports · 2026Article
- A Non-Inferiority Evaluation of YAHE 4.0, an Alphacypermethrin-PBO Insecticide-Treated Net Against Pyrethroid ResistantTropical medicine and infectious disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundInsecticide-treated nets (ITNs) incorporating pyrethroids with piperonyl butoxide (PBO) have demonstrated enhanced effectiveness against malaria transmitted by pyrethroid-resistant vectors compared with standard pyrethroid-only ITNs. To sustain progress in malaria prevention, a broader portfolio of effective pyrethroid-PBO nets is required to promote market diversity and strengthen supply resilience. In this study, we evaluated the entomological efficacy and wash durability of Vector Guard®, a novel mosaic alpha-cypermethrin-PBO ITN, against pyrethroid-resistant Anopheles gambiae sensu lato (An. gambiae s.l.) in southern Benin.
methodsAn experimental hut trial was conducted in Covè, Benin, against wild, free-flying An. gambiae s.l. The effectiveness of the Vector Guard® ITN was tested unwashed and after 20 standardized washes, and also compared to two WHO-prequalified ITNs: Olyset® Plus (a permethrin-PBO net) and Royal Sentry® 2.0 (an alpha-cypermethrin-only net). Primary outcomes were mosquito mortality and blood-feeding protection. Susceptibility bioassays were conducted to assess local vector resistance to insecticides. Laboratory cone and tunnel tests were also performed to help explain the finding in the experimental huts. Chemical content analyses were performed to investigate active ingredient wash retention. Vector Guard® was assessed for its non-inferiority to Olyset® Plus following WHO guidance.
resultsThe wild An. gambiae s.l. population at Covè exhibited high frequencies of pyrethroid resistance, with PBO pre-exposure restoring partial susceptibility to alpha-cypermethrin (34% vs 4% mortality) but not to permethrin (2.0% vs 2.1% mortality). A total of 6799 females were collected in the experimental huts. Vector Guard® outperformed both Royal Sentry® 2.0 and Olyset® Plus across all entomological endpoints. Mortality with Vector Guard® was significantly higher than with Olyset® Plus both when unwashed (36.4% vs 17.5%, p < 0.001) and after 20 washes (17.2% vs 8.7%, p < 0.001). Non-inferiority analysis with pooled data for unwashed and washed nets confirmed that Vector Guard® was non-inferior to Olyset® Plus in terms of both mortality (odds ratio [OR] 2.71, 95% confidence interval [CI] 2.26-3.24, non-inferiority margin [NIM] 0.423) and blood-feeding protection (OR 0.53, 95% CI 0.45-0.62, NIM: 1.359). These findings were supported by the results from the cone and tunnel tests. Chemical analysis showed higher wash retention of active ingredients in Vector Guard® (83% for PBO and > 94% for alpha-cypermethrin) compared to Olyset® Plus (40.2% for PBO and 69.6% for permethrin).
conclusionsVector Guard® demonstrated superior entomological efficacy and wash durability compared to Royal Sentry® 2.0 and Olyset® Plus, and fulfilled WHO non-inferiority criteria for mosquito mortality and blood-feeding inhibition. These findings support its addition to the WHO list of prequalified pyrethroid-PBO ITNs and its potential to provide improved malaria control when deployed on a large scale in areas with high levels of pyrethroid resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.